Tuesday, May 16, 2017

Clipping out cancer with Caribou Biosciences | Disrupt NY 2017


Rachel Haurwitz of Caribou Biosciences talks to Sarah Buhr about what CRISPR makes possible, the ongoing IP battle over the tech, and the current regulatory environment. Subscribe to TechCrunch today: http://bit.ly/18J0X2e TechCrunch Disrupt is the world’s leading authority in debuting revolutionary startups, introducing game-changing technologies and discussing what’s top of mind for the tech industry’s key innovators. Watch more from Disrupt NY day two here: https://www.youtube.com/watch?v=mNJaRKiOYic TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.
by TechCrunch via Endless Supplies .Us - Brands

No comments: